-
Something wrong with this record ?
Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity
G. Bouz, L. Semelková, O. Janďourek, K. Konečná, P. Paterová, L. Navrátilová, V. Kubíček, J. Kuneš, M. Doležal, J. Zitko,
Language English Country Switzerland
Document type Journal Article
Grant support
SVV 260 401
Ministry of Education, Youth and Sports of the Czech Republic
CZ.02.1.01/0.0/0.0/16_019/0000841
EFSA-CDN co-funded by ERDF
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 1997-01-01
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2009-03-01
Health & Medicine (ProQuest)
from 1997-01-01
- MeSH
- Anti-Bacterial Agents chemical synthesis chemistry pharmacology MeSH
- Antifungal Agents pharmacology MeSH
- Bacteria drug effects MeSH
- Cell Death drug effects MeSH
- Hep G2 Cells MeSH
- Fungi drug effects MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Molecular Conformation MeSH
- Pyrazines chemical synthesis chemistry pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
We report the design, synthesis, and in vitro antimicrobial activity of a series of N-substituted 3-aminopyrazine-2-carboxamides with free amino groups in position 3 on the pyrazine ring. Based on various substituents on the carboxamidic moiety, the series is subdivided into benzyl, alkyl, and phenyl derivatives. The three-dimensional structures of the title compounds were predicted using energy minimization and low mode molecular dynamics under AMBER10:EHT forcefield. Compounds were evaluated for antimycobacterial, antibacterial, and antifungal activities in vitro. The most active compound against Mycobacterium tuberculosis H37Rv (Mtb) was 3-amino-N-(2,4-dimethoxyphenyl)pyrazine-2-carboxamide (17, MIC = 12.5 μg/mL, 46 μM). Antimycobacterial activity against Mtb and M. kansasii along with antibacterial activity increased among the alkyl derivatives with increasing the length of carbon side chain. Antibacterial activity was observed for phenyl and alkyl derivatives, but not for benzyl derivatives. Antifungal activity was observed in all structural subtypes, mainly against Trichophyton interdigitale and Candida albicans. The four most active compounds (compounds 10, 16, 17, 20) were evaluated for their in vitro cytotoxicity in HepG2 cancer cell line; only compound 20 was found to exert some level of cytotoxicity. Compounds belonging to the current series were compared to previously published, structurally related compounds in terms of antimicrobial activity to draw structure activity relationships conclusions.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034683
- 003
- CZ-PrNML
- 005
- 20240528080859.0
- 007
- ta
- 008
- 191007s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules24071212 $2 doi
- 035 __
- $a (PubMed)30925695
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bouz, Ghada $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. bouzg@faf.cuni.cz.
- 245 10
- $a Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity / $c G. Bouz, L. Semelková, O. Janďourek, K. Konečná, P. Paterová, L. Navrátilová, V. Kubíček, J. Kuneš, M. Doležal, J. Zitko,
- 520 9_
- $a We report the design, synthesis, and in vitro antimicrobial activity of a series of N-substituted 3-aminopyrazine-2-carboxamides with free amino groups in position 3 on the pyrazine ring. Based on various substituents on the carboxamidic moiety, the series is subdivided into benzyl, alkyl, and phenyl derivatives. The three-dimensional structures of the title compounds were predicted using energy minimization and low mode molecular dynamics under AMBER10:EHT forcefield. Compounds were evaluated for antimycobacterial, antibacterial, and antifungal activities in vitro. The most active compound against Mycobacterium tuberculosis H37Rv (Mtb) was 3-amino-N-(2,4-dimethoxyphenyl)pyrazine-2-carboxamide (17, MIC = 12.5 μg/mL, 46 μM). Antimycobacterial activity against Mtb and M. kansasii along with antibacterial activity increased among the alkyl derivatives with increasing the length of carbon side chain. Antibacterial activity was observed for phenyl and alkyl derivatives, but not for benzyl derivatives. Antifungal activity was observed in all structural subtypes, mainly against Trichophyton interdigitale and Candida albicans. The four most active compounds (compounds 10, 16, 17, 20) were evaluated for their in vitro cytotoxicity in HepG2 cancer cell line; only compound 20 was found to exert some level of cytotoxicity. Compounds belonging to the current series were compared to previously published, structurally related compounds in terms of antimicrobial activity to draw structure activity relationships conclusions.
- 650 _2
- $a antibakteriální látky $x chemická syntéza $x chemie $x farmakologie $7 D000900
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a Bacteria $x účinky léků $7 D001419
- 650 _2
- $a buněčná smrt $x účinky léků $7 D016923
- 650 _2
- $a houby $x účinky léků $7 D005658
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a pyraziny $x chemická syntéza $x chemie $x farmakologie $7 D011719
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Semelková, Lucia $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. lucia.semelkova@seznam.cz.
- 700 1_
- $a Janďourek, Ondřej $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. jando6aa@faf.cuni.cz.
- 700 1_
- $a Konečná, Klára $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. konecna@faf.cuni.cz.
- 700 1_
- $a Paterová, Pavla $u Department of Clinical Microbiology, Faculty Hospital, Sokolská 581, 500 05 Hradec Králové, Czech Republic. pavla.paterova@fnhk.cz.
- 700 1_
- $a Navrátilová, Lucie $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. navratl2@faf.cuni.cz.
- 700 1_
- $a Kubíček, Vladimír $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. kubicek@faf.cuni.cz.
- 700 1_
- $a Kuneš, Jiří $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. kunes@faf.cuni.cz.
- 700 1_
- $a Doležal, Martin, $d 1961- $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. dolezalm@faf.cuni.cz. $7 jn19981000714
- 700 1_
- $a Zitko, Jan $u Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. jan.zitko@faf.cuni.cz.
- 773 0_
- $w MED00180394 $t Molecules $x 1420-3049 $g Roč. 24, č. 7 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30925695 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20240528080856 $b ABA008
- 999 __
- $a ok $b bmc $g 1451343 $s 1073233
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 24 $c 7 $e 20190328 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a SVV 260 401 $p Ministry of Education, Youth and Sports of the Czech Republic
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000841 $p EFSA-CDN co-funded by ERDF
- LZP __
- $a Pubmed-20191007